Luis Fandos, MD
Interventional Pain Medicine · Babylon, NYNPI 1376572594
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.1%), other and consulting fees — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by International Rehabilitative Sciences, Inc at 24.1% of the total. Among interventional pain medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 893 payments — averaging $35.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- International Rehabilitative Sciences, Inc$8K
- Elliquence, LLC$5K
- Relievant Medsystems, Inc.$3K
- Boston Scientific$3K
- Abbott$1K
- AbbVie$1K
- plus $11K from 54 others
What the payments were for
- Consulting fees$5,00016%
- Speaking & faculty fees$4952%
- Travel & lodging$1,0813%
- Food & beverage$17,43055%
- Education$500%
- Other$7,58924%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RS 4i Plus Sequential Stimulator$7,589
- RS-LBG, RS-FBG$7,589
- Intracept$3,781
- Prolate$674
- InSpan$595
- SIJFuse$495
- FacetFuse$495
- NanoFuse$495
- Evoke$323
- Prospera$259
- CFNS StimQ Peripheral Nerve StimulatorSystem$189
- SCS FreedonSpinal Cord Stimulator$189
- Nalocet$169
- Axonics r-SNM System$157
- Proclaim IPG$145
- Nalu Neurostimulation System$141
- GENERAL PAIN MANAGEMENT$126
- ReActiv8$111
- PROCLAIM$101
- Sacrix$100
How this compares
$31,646 in reported general payments places this provider in the 90th percentile of 132 interventional pain medicine providers in New York.
See all interventional pain medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 20 | $23,287 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 214 | $6,829 |
| Diclofenac Sodium | 46 | $4,387 |
| Lidocaine | 21 | $1,916 |
| Oxycodone Hcl | 59 | $988 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $725 |
| Gabapentin | 79 | $687 |
| Tizanidine Hcl | 84 | $591 |
| ProgesteroneProgesterone, Micronized | 45 | $582 |
| Liothyronine Sodium | 24 | $542 |
| Hydromorphone Hcl | 34 | $533 |
| Tramadol Hcl | 103 | $514 |
| Pregabalin | 26 | $437 |
| Lactulose | 59 | $421 |
| Morphine Sulfate | 12 | $285 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Virtus Pharmaceuticals LLCLactulose | $223 | $42159 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 132 interventional pain medicine providers in New York.
Other interventional pain medicine in Babylon
- Daniel KohaneBabylon$27K
- Jonathan FinkelsteinBabylon$11K
- Sunil AlbertBabylon$10K
- Corey HunterNew York$446K
- Neel MehtaNew York$432K
- Hemant KaliaRochester$179K
- Martin FerrilloAlbany$164K
- George ChaseKew Gardens$102K
- Kimberly SackheimNew York$102K
- Suelane OuroNew York$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.